Recurrent Stent thrombosis in a patient with antiphospholipid syndrome and dual anti-platelet therapy non-responsiveness

7Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

Abstract

Antiphospholipid syndrome (APS), the most common acquired hypercoagulable condition, is diagnosed by persistent presence of antiphospholipid antibodies and episodes of vascular thrombosis. It may be an important predisposing factor for stent thrombosis, resulting in poor outcomes. Also, anti-platelet therapy non-responsiveness is associated with stent thrombosis. We report a case of a 39-year-old man who after undergoing successful percutaneous coronary intervention for significant coronary artery disease suffered repeated stent thrombosis events leading to ST-segment elevation myocardial infarction. Eventually, he underwent coronary artery bypass surgery because of uncontrolled thrombosis and was diagnosed as having APS and dual antiplatelet therapy non-responsiveness.

Cite

CITATION STYLE

APA

Lee, Y. H., Yang, H. M., Tahk, S. J., Hong, Y. S., Park, J. S., Seo, K. W., … Noh, C. K. (2015). Recurrent Stent thrombosis in a patient with antiphospholipid syndrome and dual anti-platelet therapy non-responsiveness. Korean Circulation Journal, 45(1), 71–76. https://doi.org/10.4070/kcj.2015.45.1.71

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free